SE0402029D0 - Prostaglandin a derivatieves for the treatment of psoriasis - Google Patents

Prostaglandin a derivatieves for the treatment of psoriasis

Info

Publication number
SE0402029D0
SE0402029D0 SE0402029A SE0402029A SE0402029D0 SE 0402029 D0 SE0402029 D0 SE 0402029D0 SE 0402029 A SE0402029 A SE 0402029A SE 0402029 A SE0402029 A SE 0402029A SE 0402029 D0 SE0402029 D0 SE 0402029D0
Authority
SE
Sweden
Prior art keywords
treatment
prostaglandin
psoriasis
derivative
derivatives
Prior art date
Application number
SE0402029A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Priority to SE0402029A priority Critical patent/SE0402029D0/sv
Publication of SE0402029D0 publication Critical patent/SE0402029D0/sv
Priority to EP05772489A priority patent/EP1786432A1/en
Priority to JP2007527142A priority patent/JP2008509994A/ja
Priority to US11/204,491 priority patent/US20060041016A1/en
Priority to PCT/SE2005/001213 priority patent/WO2006019353A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0402029A 2004-08-17 2004-08-17 Prostaglandin a derivatieves for the treatment of psoriasis SE0402029D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0402029A SE0402029D0 (sv) 2004-08-17 2004-08-17 Prostaglandin a derivatieves for the treatment of psoriasis
EP05772489A EP1786432A1 (en) 2004-08-17 2005-08-16 Arrangement for the removal of an absorbent article from a stack of absorbent articles
JP2007527142A JP2008509994A (ja) 2004-08-17 2005-08-16 乾癬の治療のための組成物および方法
US11/204,491 US20060041016A1 (en) 2004-08-17 2005-08-16 Composition and method for the treatment of psoriasis
PCT/SE2005/001213 WO2006019353A1 (en) 2004-08-17 2005-08-16 Composition and method for the treatement of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402029A SE0402029D0 (sv) 2004-08-17 2004-08-17 Prostaglandin a derivatieves for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
SE0402029D0 true SE0402029D0 (sv) 2004-08-17

Family

ID=32960402

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402029A SE0402029D0 (sv) 2004-08-17 2004-08-17 Prostaglandin a derivatieves for the treatment of psoriasis

Country Status (5)

Country Link
US (1) US20060041016A1 (sv)
EP (1) EP1786432A1 (sv)
JP (1) JP2008509994A (sv)
SE (1) SE0402029D0 (sv)
WO (1) WO2006019353A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288133B1 (es) 2006-06-12 2008-09-16 Maria Cristina Fernandez Rodriguez Composicion topica para el tratamiento de la psoriasis.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
ES2186670T3 (es) * 1988-09-06 2003-05-16 Pharmacia Ab Derivados de prostaglandina para el tratamiento del glaucoma o la hipertension ocular.
SE9403158D0 (sv) * 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins
WO1998000100A1 (en) * 1996-07-03 1998-01-08 The Board Of Regents Of The University Of Oklahoma Enhancement of skin pigmentation by prostaglandins
US20050159485A1 (en) * 2002-01-04 2005-07-21 Jost-Price Edward R. Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
AU2003228819A1 (en) * 2002-05-03 2003-11-17 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
JPWO2004005509A1 (ja) * 2002-07-02 2005-11-04 株式会社ジェノックス創薬研究所 アレルギー性疾患の検査方法、および治療のための薬剤

Also Published As

Publication number Publication date
WO2006019353A1 (en) 2006-02-23
WO2006019353A9 (en) 2006-06-01
JP2008509994A (ja) 2008-04-03
US20060041016A1 (en) 2006-02-23
EP1786432A1 (en) 2007-05-23

Similar Documents

Publication Publication Date Title
CY1111433T1 (el) Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης
TNSN06294A1 (en) Galenic formulations of organic compounds
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
WO2006063111A3 (en) Pharmaceutical formulations cytidine analogs and derivatives
ATE323498T1 (de) Oligosaccharidealdonsäure und ihre topische verabreichung
HRP20110497T1 (hr) Postupci za primjenu kompozicija aminopiridina sa produženim oslobađanjem
RS50593B (sr) Oktenidinske pastile protiv bolesti zapaljenja usta i ždrela
CR10167A (es) "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor"
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
NO20052490L (no) Dagsdoseringsenheter for melatonin.
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
WO2003073981A3 (en) Novel of cytokine inhibitors
WO2009109654A3 (en) 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40
SE9403158D0 (sv) New use of prostaglandins
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
UA89795C2 (ru) Фармацевтическая композиция, которая содержит эстер темозоломида
SE0102440D0 (sv) New compound
RU2007138263A (ru) Противовоспалительные соединения
PT1414467E (pt) Tratamento topico da mastalgia
SE0004101D0 (sv) New use
SE0402029D0 (sv) Prostaglandin a derivatieves for the treatment of psoriasis
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
ITMI942645A1 (it) Uso di derivati guanidin-imidazolici per coadiuvare la stimolazione della crescita dei capelli.